Award
National Cancer Institute RFA-CA-22-041
Investigating retrotransposon activity-mediated EMT plasticity and immune cell dysfunction in pancreatic ductal adenocarcinoma
Recipient
Massachusetts General Hospital
Award Amount
$107,535.00
Ceiling
$107,535.00
Awarded
September 08, 2025
Identifier
RFA-CA-22-041
Research project grant awarded to investigate the role of retrotransposon activity in EMT plasticity and immune dysfunction in pancreatic ductal adenocarcinoma.
Description
This project aims to elucidate the molecular and cellular mechanisms driving tumor heterogeneity and immune response in lung and pancreas cancers, with a focus on chromatin regulation and tumor suppressor genes.